Adjuvant and neoadjuvant therapy in non-small cell lung cancer

Keyphrases

• 5-year Survival 33%
• Adjuvant Chemotherapy 66%
• Adjuvant Therapy 100%
• Before Surgery 33%
• Completely Resected 33%
• Downstaging 33%
• Early-stage Lung Cancer 66%
• Induction Chemotherapy 33%
• Lung Cancer Patients 33%
• Metastatic Disease 33%
• Neoadjuvant Chemotherapy 100%
• Neoadjuvant Therapy 100%
• Non-small Cell Lung Cancer (NSCLC) 100%
• Pathological Stage 33%
• Patient's Will 33%
• Recurrent Disease 33%
• Recurrent Metastatic 33%
• Resection 66%
• Standard of Care 66%
• Surgical Resection 66%
• Survival Rate 33%
• Treatment Strategy 33%

Medicine and Dentistry

• Adjuvant Chemotherapy 50%
• Adjuvant Therapy 100%
• Clinical Stage 25%
• Diseases 75%
• Induction Chemotherapy 25%
• Lung Cancer 25%
• Metastatic Carcinoma 25%
• Neoadjuvant Chemotherapy 75%
• Neoadjuvant Therapy 100%
• Non Small Cell Lung Cancer 100%
• Recurrent Disease 25%
• Surgery 100%
• Survival Rate 50%